September 2018

Biosimilar-Use-In-Cancer-Treatment
USA
Canada

Biosimilar Use in Cancer Treatment – Current attitudes and perceptions

Biological drugs, protein-based products derived from living cells using biotechnology, have been used since the 1990’s as a treatment option for cancer patients. Since 2009, biosimilar therapies (therapeutically equivalent subsequent entry biologics) have been available in different therapeutic areas in Canada, and are now on the verge of becoming available for use in oncology....

CTA

We are here to answer your questions.

Ready to explore how data-driven insights can accelerate your pharmaceutical research? Connect with our team to discuss your goals.